Patients with inflammatory bowel disease (IBD) are at risk for certain malignancies. We aimed to determine the risk of melanoma and nonmelanoma skin cancer (NMSC) in patients with IBD and how medications affect these risks
Objective. Patients with inflammatory bowel disease (IBD) are at increased risk from skin cancer. Ai...
IntroductionUveal melanoma is a rare tumour caused by genetic factors and alterations in the immune ...
Data regarding the risk of gastrointestinal and extra-intestinal cancers in Crohn’s disease (CD) and...
Patients with inflammatory bowel disease (IBD) are at risk for certain malignancies. We aimed to det...
Patients with inflammatory bowel disease (IBD) might be at increased risk for certain malignancies. ...
At least 1 million new cases of non-melanoma skin cancer (NMSC) are diagnosed in the United States e...
Background: Patients with inflammatory bowel disease (IBD) are at increased risk to develop malignan...
Background Recent studies report an increased risk of non‐melanoma skin cancer (NMSC) in immunosu...
The management of inflammatory bowel disease (IBD) has changed since the mid-1990s (e.g., use of thi...
Chronic inflammation in patients with Inflammatory Bowel Disease (IBD) leads to an increased risk of...
BACKGROUND & AIMS: Our understanding of malignancy associated with immunosuppression in patients wit...
BACKGROUND Inflammatory bowel disease (IBD) is a chronic inflammatory disorder, primarily of, but...
International audienceBACKGROUND & AIMS: Patients with inflammatory bowel disease (IBD) who have bee...
Objective. Patients with inflammatory bowel disease (IBD) are at increased risk from skin cancer. Ai...
IntroductionUveal melanoma is a rare tumour caused by genetic factors and alterations in the immune ...
Data regarding the risk of gastrointestinal and extra-intestinal cancers in Crohn’s disease (CD) and...
Patients with inflammatory bowel disease (IBD) are at risk for certain malignancies. We aimed to det...
Patients with inflammatory bowel disease (IBD) might be at increased risk for certain malignancies. ...
At least 1 million new cases of non-melanoma skin cancer (NMSC) are diagnosed in the United States e...
Background: Patients with inflammatory bowel disease (IBD) are at increased risk to develop malignan...
Background Recent studies report an increased risk of non‐melanoma skin cancer (NMSC) in immunosu...
The management of inflammatory bowel disease (IBD) has changed since the mid-1990s (e.g., use of thi...
Chronic inflammation in patients with Inflammatory Bowel Disease (IBD) leads to an increased risk of...
BACKGROUND & AIMS: Our understanding of malignancy associated with immunosuppression in patients wit...
BACKGROUND Inflammatory bowel disease (IBD) is a chronic inflammatory disorder, primarily of, but...
International audienceBACKGROUND & AIMS: Patients with inflammatory bowel disease (IBD) who have bee...
Objective. Patients with inflammatory bowel disease (IBD) are at increased risk from skin cancer. Ai...
IntroductionUveal melanoma is a rare tumour caused by genetic factors and alterations in the immune ...
Data regarding the risk of gastrointestinal and extra-intestinal cancers in Crohn’s disease (CD) and...
DOI
Add to ORKG